Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
Open accessThe DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Abstract
The rapid development of nanotechnology offers a variety of potential therapeutic strategies for cancer treatment. High atomic element nanomaterials are often utilized as radiosensitizers due to their unique photoelectric decay characteristics. Among them, gold nanoparticles (GNPs) are one of the most widely investigated and are considered to be an ideal radiosensitizers for radiotherapy due to their high X-ray absorption and unique physicochemical properties. Over the last few decades, multi-disciplinary studies have focused on the design and optimization of GNPs to achieve greater dosing capability and higher therapeutic effects and highlight potential mechanisms for radiosensitization of GNPs. Although the radiosensitizing potential of GNPs has been widely recognized, its clinical translation still faces many challenges. This review analyses the different roles of GNPs as radiosensitizers in cancer radiotherapy and summarizes recent advances. In addition, the underlying mechanisms of GNP radiosensitization, including physical, chemical and biological mechanisms are discussed, which may provide new directions for the optimization and clinical transformation of next-generation GNPs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High-Z nanoparticles enhance ROS generation by increasing local energy deposition and secondary electron emission, thereby amplifying free radical formation and oxidative stress following irradiation [9,10,86,88,102,103].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nanoparticle-mediated radiosensitization has emerged as a promising strategy to enhance the therapeutic index of irradiation by combining physical dose amplification with biological, microenvironmental, and immunological modulation.”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Early studies predominantly focused on high-atomic-number (high-Z) materials, including gold, silver, gadolinium, and hafnium-based nanoparticles, with the primary objective of maximizing radiation energy deposition and secondary electron generation [9,85,95,96].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In general, materials with higher atomic numbers exhibit greater photoelectric interaction probabilities and therefore greater potential for secondary electron generation and local dose enhancement, particularly at kilovoltage photon energies [9,10,84,85,86].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“High-atomic-number (high-Z) nanomaterials interact differently with kilovoltage and megavoltage photon beams, influencing photoelectric absorption, secondary electron generation, and local energy deposition—the principal physical mechanisms underlying nanoparticle-mediated radiotherapy enhancement [9,10,85,86,88].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–216 of 216
Capacity of gold nanoparticles in cancer radiotherapy
Nagi, N. M. S., Khair, Y. A. M., & Abdalla, A. M. E. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0671-6 · Cited by 25
Metal-based nanoparticles as radio-sensitizer in gastric cancer therapy
Batooei, S., Khajeali, A., Khodadadi, R., & Islamian, J. P. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101576 · Cited by 25
Recent advances of smart acid‐responsive gold nanoparticles in tumor therapy
Zhang, Y., Yang, L., Yang, C., & Liu, J. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1619 · Cited by 24
Kefayat, A., Ghahremani, F. H., Motaghi, H., Rostami, S., & Mehrgardi, M. A. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1523417 · Cited by 23
Kim, S., & Kim, E. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1393579 · Cited by 21
Soleymanifard, S., Rostami, A., Aledavood, S. A., Matin, M. M., & Sazgarnia, A. (2016) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1268282 · Cited by 20
Yang, Y., Ren, L., & Wang, H. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0049 · Cited by 20
Kanavi, M. R., Asadi, S., Balagholi, S., Alikarami, F., Nosrati, H., & Ahmadieh, H. (2018) · Journal of Applied Clinical Medical Physics · doi:10.1002/acm2.12336 · Cited by 18
Megavoltage X-ray Dose Enhancement with Gold Nanoparticles in Tumor Bearing Mice.
Anijdan, S. H. M., Mahdavi, S. R., Shirazi, A., Zarrinfard, M. A., & Hajati, J. (2013) · Europe PMC (PubMed Central) · Cited by 18
[The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].
Jóźwiak, P., & Lipińska, A. (2012) · PubMed · doi:10.5604/17322693.988242 · Cited by 17
Abbasian, M., Baharlouei, A., Arab‐Bafrani, Z., & Lightfoot, D. A. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2769-3 · Cited by 17
Li, X., Wang, H., Lu, X., & Di, B. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.156 · Cited by 17
Synthesis and characterization of pHLIP ® coated gold nanoparticles
Daniels, J., Crawford, T. M., Andreev, O. A., & Reshetnyak, Y. K. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2017.02.008 · Cited by 16
Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges
Ishikura, S. (2012) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-011-0832-y · Cited by 15
Hatoyama, K., Kitamura, N., Takano-Kasuya, M., Tokunaga, M., Oikawa, T., Ohta, M., Hamada, Y., Tada, H., Kobayashi, Y., Kamei, T., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.016 · Cited by 13
Zhao, Z., Xu, H., Li, S., Han, Y., Jia, J., Han, Z., Zhang, D., Zhang, L., Yu, R., & Liu, H. (2019) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2019.2830 · Cited by 12
Research works printed but not linked: 9
- Shrestha, 2016, Jacobs J Radiat Oncol, 3, 026
- Linam, 2015, Anticancer Res, 35, 2479
- Babaei, 2014, Nanomed J, 1, 211
- Mousavie Anijdan, 2013, Int J Mol Cell Med, 2, 118
- Eblan, 2013, Transl Cancer Res, 2, 320
- Jóźwiak, 2012, Postepy Hig Med Dosw, 66, 165
- Hu, 2015, Int J Nanomed, 10, 2065
- Kalmouni, 2019, Cell Mol Life Sci, 76, 2171
- Daniels, 2017, Biochem Biophys Rep, 10, 62
Cited by
Gold nanoparticles and gold nanorods in the landscape of cancer therapy
Kesharwani, P., Ma, R., Sang, L., Fatima, M., Sheikh, A., Abourehab, M. A. S., Gupta, N., Chen, Z.-S., & Zhou, Y. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01798-8 · Cited by 337
Gold nanoparticles (GNPs) in biomedical and clinical applications: A review
Anik, M. I., Mahmud, N., Al Masud, A., & Hasan, M. (2022) · Nano Select · doi:10.1002/nano.202100255 · Cited by 228
An Overview on Gold Nanorods as Versatile Nanoparticles in Cancer Therapy
Nejabat, M., Samie, A., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.009 · Cited by 119
Prospects of nanoparticle-based radioenhancement for radiotherapy
Gerken, L. R. H., Gerdes, M. E., Pruschy, M. N., & Herrmann, I. K. (2023) · Materials Horizons · doi:10.1039/d3mh00265a · Cited by 123
Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities
Rashidi, N., Davidson, M., Apostolopoulos, V., & Nurgali, K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105599 · Cited by 118
Metadata
- Authors
- Chen, Y., Yang, J., Fu, S., & Wu, J.
- Affiliations
- Southwest Medical University (CN)
- Corresponding author
- Fu, Shaozhi
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2020-11
- Volume
- Volume 15
- Pages
- 9407-9430
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC7699443
- OpenAlex
- W3108978735
- Cited by
- 319
- References
- 216
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 62 · 2023: 79 · 2022: 45 · 2021: 22
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Servier
- Southwest Medical University (2013LZLY-J40, 14JC0144)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- gold nanoparticles, radiosensitizers, cancer radiotherapy, radiosensitization mechanism, X-ray absorption, nanoparticle design, clinical translation, nanomedicine
- MeSH terms
- Gold, Humans, Neoplasms, Radiation-Sensitizing Agents, Nanomedicine, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



